Children's Hospital Medical Center, Cincinnati
Cincinnati, Ohio, 45229, United States
Location status: Recruiting
Location contact
Jeffrey Alten
PRINCIPAL_INVESTIGATOR
Jeffrey Alten, MD
CONTACT
Lindsay Fist
CONTACT
NCT Number: NCT07478354
The purpose of this protocol is to redefine the Heart Institute BioRepository (HIBR) to facilitate Investigator-initiated and programmatic basic, translational, clinical and outcomes research. For the purposes of this protocol, "tissue" will refer to any gross specimen obtained from a patient, including but not limited to blood, cardiovascular tissue, urine, saliva, and other tissues and bodily fluids, including explanted non-human prosthetics or grafts. In this context, "tissue" is synonymous with "sample" or "specimen." A "BioRepository" functions to systematically collect, maintain and govern tissue specimens.
Interested in participating?
Request InfoAll sexes
Observational
Cincinnati, Ohio, 45229, United States
Location status: Recruiting
Jeffrey Alten
PRINCIPAL_INVESTIGATOR
Jeffrey Alten, MD
CONTACT
Lindsay Fist
CONTACT
The HIBR is a prospective and retrospective observational repository. Designed as a core facility for Heart Institute investigators, it will grow into an institutional and eventually national resource. Located in dedicated research space within the Heart Institute, HIBR acquires, processes, organizes, and stores tissue and blood samples for current and future studies. Whole blood is used for DNA isolation, and the repository can perform limited wet-bench functions, including plasma isolation and B-lymphocyte transformation to generate immortalized cell lines and preserve genomic material. Samples may be collected at multiple time points, including during surgery, outpatient clinic visits, the perinatal period, and cardiac catheterizations, to capture comprehensive biological data across clinical encounters.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Day 1
Blood samples will be collected for preparation of plasma and serum, extraction of DNA and isolation of circulating cells. Future analysis includes genotype-phenotype relationships using blood-tissue pairs.
Time frame: Day 1
Demographic information, outcomes, risk factor, and other clinical data
Contact information is provided by the study sponsor or research team.
Children's Hospital Medical Center, Cincinnati
Other
Acronym: HIBR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07724522
Body Weight, Cardiovascular Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT07704164
Arterial Occlusive Diseases, Arteriosclerosis
Barcelona, Spain
View Trial DetailsNCT07483502
Cardiovascular Diseases, Cardiovascular Diseases (CVD)
Hull, East Riding Of Yorkshire, United Kingdom
View Trial DetailsNCT07252531
Cardiovascular Diseases, Cardiovascular Diseases (CVD)
Rotterdam, Netherlands
View Trial Details